Cutaneous vasculitis and glomerulonephritis in a patient taking the anti-TNF alpha agent etanercept for rheumatoid arthritis

Joint Bone Spine. 2004 Sep;71(5):444-5. doi: 10.1016/j.jbspin.2004.05.008.
No abstract available

Publication types

  • Case Reports
  • Letter

MeSH terms

  • Adult
  • Anti-Inflammatory Agents, Non-Steroidal / adverse effects*
  • Anti-Inflammatory Agents, Non-Steroidal / therapeutic use
  • Arthritis, Rheumatoid / drug therapy*
  • Etanercept
  • Female
  • Glomerulonephritis / chemically induced*
  • Humans
  • Immunoglobulin G / adverse effects*
  • Immunoglobulin G / therapeutic use
  • Receptors, Tumor Necrosis Factor / therapeutic use
  • Skin Diseases, Vascular / chemically induced*
  • Vasculitis / chemically induced*

Substances

  • Anti-Inflammatory Agents, Non-Steroidal
  • Immunoglobulin G
  • Receptors, Tumor Necrosis Factor
  • Etanercept